Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
TELA Bio, Inc. - Common stock
(NQ:
TELA
)
0.7461
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about TELA Bio, Inc. - Common stock
< Previous
1
2
3
4
5
6
Next >
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
October 24, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 23, 2024
Via
Benzinga
Demystifying TELA Bio: Insights From 6 Analyst Reviews
↗
October 04, 2024
Via
Benzinga
Recap: TELA Bio Q4 Earnings
↗
March 21, 2024
Via
Benzinga
Preview: TELA Bio's Earnings
↗
March 20, 2024
Via
Benzinga
TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
October 23, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 22, 2024
Via
Benzinga
TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
October 22, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Third Quarter 2024 Financial Results
October 17, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
Crude Oil Down 2%; Paysafe Shares Surge After Q2 Results
↗
August 13, 2024
Via
Benzinga
S&P 500 Gains 1%; Home Depot Earnings Top Views
↗
August 13, 2024
Via
Benzinga
Topics
Stocks
Nasdaq Surges 200 Points; US Producer Prices Increase 0.1% In July
↗
August 13, 2024
Via
Benzinga
TELA Stock Earnings: TELA Bio Misses EPS, Misses Revenue for Q2 2024
↗
August 12, 2024
TELA stock results show that TELA Bio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance
August 12, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference
July 25, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Second Quarter 2024 Financial Results
July 22, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Appoints Jeffrey Blizard to its Board of Directors
June 04, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Appoints Greg Firestone as Chief Commercial Officer
May 20, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 10, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q1 2024
↗
May 09, 2024
TELA stock results show that TELA Bio missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
May 09, 2024
Via
Benzinga
TELA Bio Reports First Quarter 2024 Financial Results
May 09, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce First Quarter 2024 Financial Results
April 25, 2024
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
April 15, 2024
Targets the more than 665,000 inguinal hernia procedures performed annually in the United States (U.S.)
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
April 08, 2024
Howard N. Langstein, MD, FACS joins innovative MedTech company to leverage his vast experience to help other surgeons optimize clinical outcomes in plastic and reconstructive surgery
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q4 2023
↗
March 21, 2024
TELA stock results show that TELA Bio missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
March 21, 2024
Strong and secure, LIQUIFIX is the first approved adhesive-based product to affix mesh without penetrating patient tissue
From
TELA Bio, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 21, 2024
↗
March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
